Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma

Clinical trial NCT00389285 · COMPLETED

Trial details

NCT number: NCT00389285
Sponsor: ZymoGenetics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2006-10-01
Primary completion: 2009-05-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.